Literature DB >> 4008528

SERGE, the subcellular site of initial hepatic glycogen deposition in the rat: a radioautographic and cytochemical study.

R R Cardell, J E Michaels, J T Hung, E L Cardell.   

Abstract

Hormonal control of hepatic glycogen and blood glucose levels is one of the major homeostatic mechanisms in mammals: glycogen is synthesized when portal glucose concentration is sufficiently elevated and degraded when glucose levels are low. We have studied initial events of hepatic glycogen synthesis by injecting the synthetic glucocorticoid dexamethasone (DEX) into adrenalectomized rats fasted overnight. Hepatic glycogen levels are very low in adrenalectomized rats, and DEX causes rapid deposition of the complex carbohydrate. Investigation of the process of glycogen deposition was performed by light and electron microscopic (EM) radioautography using [3H]galactose as a glycogen precursor. Rats injected with DEX for 2-3 h and [3H]galactose one hour before being killed displayed an increasing number of intensely labeled hepatocytes. EM radioautography revealed silver grains over small (+/- 1 micron) ovoid or round areas of the cytosome that were rich in smooth endoplasmic reticulum (SER) and contained a high concentration of small dense particles. These distinct areas or foci of SER and presumptive glycogen (SERGE) were most numerous during initial periods of glycogen synthesis. After longer exposure to DEX (4-5 h) more typical deposits of cytoplasmic glycogen were evident in the SERGE regions. Several criteria indicated that the SERGE foci contained glycogen or presumptive glycogen: resemblance of the largest dense particles to beta-glycogen particles in EM; association of 3H-carbohydrate with the foci; removal of particles and label with alpha-amylase; and positive reaction with periodic acid-chromic acid-silver methenamine. The concentration of SER in the small foci and the association of newly formed glycogen particles with elements of SER suggest a role for this organelle in the initial synthesis of glycogen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008528      PMCID: PMC2113616          DOI: 10.1083/jcb.101.1.201

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  26 in total

1.  An electron microscope study of the early effects of 3'-Me-DAB on rat liver cells.

Authors:  K R PORTER; C BRUNI
Journal:  Cancer Res       Date:  1959-11       Impact factor: 12.701

2.  Tissue effects of glucocorticoids.

Authors:  J D Baxter; P H Forsham
Journal:  Am J Med       Date:  1972-11       Impact factor: 4.965

Review 3.  New aspects of glycogen metabolism.

Authors:  B E Ryman; W J Whelan
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1971

4.  Action of metabolic hormones on the fine structure of rat liver cells. III. Effects of adrenalectomy and administration of cortisone.

Authors:  R R Cardell
Journal:  Anat Rec       Date:  1974-10

5.  An improved silver methenamine technique for the detection of periodic acid-reactive complex carbohydrates with the electron microscope.

Authors:  A Rambourg
Journal:  J Histochem Cytochem       Date:  1967-07       Impact factor: 2.479

6.  A reliable, standardized method for ultrastructural electron microscopic radioautography.

Authors:  B M Kopriwa
Journal:  Histochemie       Date:  1973-10-03

Review 7.  Morphological and histochemical aspects of glycoproteins at the surface of animal cells.

Authors:  A Rambourg
Journal:  Int Rev Cytol       Date:  1971

8.  Hepatic glycogen patterns in fasted and fed rats.

Authors:  M B Babcock; R R Cardell
Journal:  Am J Anat       Date:  1974-07

9.  A precursor of glycogen biosynthesis: alpha-1,4-glucan-protein.

Authors:  C R Krisman; R Barengo
Journal:  Eur J Biochem       Date:  1975-03-03

10.  Relationship between glycogen and agranular endoplasmic reticulum in rat hepatic cells.

Authors:  J C de Man; A P Blok
Journal:  J Histochem Cytochem       Date:  1966-02       Impact factor: 2.479

View more
  7 in total

Review 1.  Glycogen and its metabolism: some new developments and old themes.

Authors:  Peter J Roach; Anna A Depaoli-Roach; Thomas D Hurley; Vincent S Tagliabracci
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

2.  Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism.

Authors:  Sixin Jiang; Brigitte Heller; Vincent S Tagliabracci; Lanmin Zhai; Jose M Irimia; Anna A DePaoli-Roach; Clark D Wells; Alexander V Skurat; Peter J Roach
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

3.  Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene.

Authors:  J L Parkes; R R Cardell; F C Hubbard; D Hubbard; A Meltzer; A Penn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

4.  The influence of buffers during fixation on the appearance of smooth endoplasmic reticulum and glycogen in hepatocytes of normal and glycogen-depleted rats.

Authors:  D Kuhn; P Wild
Journal:  Histochemistry       Date:  1992

5.  Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: Identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1.

Authors:  Sixin Jiang; Clark D Wells; Peter J Roach
Journal:  Biochem Biophys Res Commun       Date:  2011-08-27       Impact factor: 3.575

6.  Immunogold-silver staining and epipolarized light microscopic detection of phosphoenolpyruvate carboxykinase and glycogen phosphorylase in rat liver.

Authors:  K Gao; R E Morris; B F Giffin; R R Cardell
Journal:  Histochemistry       Date:  1993-05

7.  Phosphodiesterase 3B is localized in caveolae and smooth ER in mouse hepatocytes and is important in the regulation of glucose and lipid metabolism.

Authors:  Karin Berger; Rebecka Lindh; Nils Wierup; Emilia Zmuda-Trzebiatowska; Andreas Lindqvist; Vincent C Manganiello; Eva Degerman
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.